Endo Offers To End Tenn. Opioid Baby Suit For $35M

Law360 (July 22, 2021, 5:08 PM EDT) -- Endo Pharmaceuticals on Thursday announced a proposed $35 million deal in a suit seeking $2.4 billion in damages that was brought by Tennessee local governments on behalf of a baby who was born dependent on opioids, occurring just before trial was set to start in state court.

If approved by all the plaintiffs in the suit — which in addition to the child referred to as "Baby Doe," comprise nine counties and 18 cities and towns — the deal will end claims that Endo and two other companies knowingly participated in the illegal drug market by flooding the state with opioids. A...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!